Hong Kong stock anomaly | Xian Sheng Pharmaceutical (02096.HK) up more than 3%, the NDA for Ludeqi Biomechanical Monoclonal Antibody in collaboration with Kangnuode Biomedical has been accepted by the National Medical Products Administration.
According to the Securities Times News App, Sinopharm Holdings (02096.HK) rose more than 3%, closing at a 3.08% increase to HK$10.74, with a turnover of HK$48.8345 million as of the time of publication.
Latest
